Drug Shortage Report for TARO-IMIPENEM-CILASTATIN
| Report ID | 138546 |
| Drug Identification Number | 02351706 |
| Brand name | TARO-IMIPENEM-CILASTATIN |
| Common or Proper name | IMIPENEM-CILASTATIN |
| Company Name | SUN PHARMA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CILASTATIN IMIPENEM |
| Strength(s) | 500MG 500MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 30 |
| ATC code | J01DH |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-11-25 |
| Estimated end date | 2021-05-21 |
| Actual end date | 2021-06-03 |
| Shortage status | Resolved |
| Updated date | 2021-06-16 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2021-06-16 | French | Compare |
| v4 | 2021-06-16 | English | Compare |
| v3 | 2021-05-01 | French | Compare |
| v2 | 2021-05-01 | English | Compare |
| v1 | 2021-05-01 | English | Compare |
Showing 1 to 5 of 5